22.20Open22.20Pre Close0 Volume1 Open Interest30.00Strike Price0.00Turnover439.66%IV24.49%PremiumJul 19, 2024Expiry Date19.67Intrinsic Value100Multiplier6DDays to Expiry2.53Extrinsic Value100Contract SizeAmericanOptions Type-0.9324Delta0.0219Gamma0.52Leverage Ratio-0.0518Theta-0.0036Rho-0.49Eff Leverage0.0018Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet